Clinical Dermatology Review (Jan 2022)

Hidradenitis suppurativa: A review of available immunotherapeutic agents and advancement in treatment

  • Ana Preda-Naumescu,
  • Josiah Sowell,
  • Hana N Ahmed,
  • Tiffany T Mayo,
  • Nabiha Yusuf

DOI
https://doi.org/10.4103/cdr.cdr_53_21
Journal volume & issue
Vol. 6, no. 2
pp. 88 – 96

Abstract

Read online

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that poses a significant diagnostic, as well as therapeutic, challenge for clinicians. The purpose of this review is to explore current treatment guidelines, as well as the newer, investigative immunotherapies, used in the management of HS. Through a detailed, albeit nonexhaustive, literature review, the most-recently published management guidelines and clinical trials concerning HS therapy were identified and their implication in current and future disease management was explored. An understanding of available treatment options, and what lies on the horizon, is important as researchers and clinicians work toward better understanding this unique disease.

Keywords